Cargando…

Guidelines for Rational and Cost-Effective Use of iNO Therapy in Term and Preterm Infants

Inhaled nitric oxide (iNO) is an effective but costly therapy for infants with hypoxemic respiratory failure. The approved and solidly evidence-based indication is for treatment of late preterm and term infants with persistent pulmonary hypertension of the newborn (PPHN); however, off-label use of i...

Descripción completa

Detalles Bibliográficos
Autor principal: Keszler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743146/
https://www.ncbi.nlm.nih.gov/pubmed/24027689
http://dx.doi.org/10.4103/2249-4847.96739